Following on from their entry into the home healthcare business through their acquisition of Respironics, Philips has now acquired Medel, a leading aerosol therapy business based in Italy. As a bonus they also get an established manufacturing base in Guangdong, China.
According to CEO Don Spence:
Philips Home Healthcare Solutions CEO Don Spence, who in November 2008 succeeded former chief executive John Miclot, said: “When Philips acquired Respironics, the company also had a leading respiratory drug delivery business. Building upon that strength and fulfilling on our ambition to expand our high-growth compressor nebulizer systems franchise, we decided to acquire the aerosol therapy business of Medel which allows us to better serve the needs of our customers and their patients who suffer from asthma, chronic obstructive pulmonary disease (COPD), cystic fibrosis and other respiratory disorders.”
This is another smart move by Philips exanding it’s position in the higher value end of the homecare business as well as the drug delivery side homecare.
The question is what next in homecare? Diabetic therapies (also fits drug delivery), dialysis… or perhaps the most obvious, wound care. We could suggest several great candidates.
We have blogged quite a lot about the homecare respiratory business (including) about Respironics in the past. you may find this background interesting.
